2007-08 INFLUENZA PREVENTION & CONTROL RECOMMENDATIONS

Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Selected Highlights

On October 24, 2007 CDC's Advisory Committee on Immunization Practices (ACIP) recommended expanding the use of the nasal influenza vaccine LAIV (FluMist®) to include healthy children ages 2-4 years old (24-59 months old) without a history of asthma or recurrent wheezing. The vaccine continues to be recommended for healthy persons ages 5-49 years who are not pregnant. "Healthy" indicates persons who do not have an underlying medical condition that predisposes them to influenza complications.

NOTE: For 2008-09 Influenza Prevention and Control Recommendations see Prevention & Control of Influenza - Recommendations of the Advisory Committee on Immunization Practices (ACIP) 2008. MMWR 2008 Jul 17; Early Release:1-60. (Also available as PDF, 586K).

NOTE: The links below refer to text that is taken directly from  Prevention & Control of Influenza - Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2007 Jul 13;56(RR06):1-54. Also available as PDF (720K).

Overview

• Primary Changes and Updates in the 2007 Recommendations
• Introduction & Biology of Influenza

Diagnosis

• Clinical Signs & Symptoms

Vaccination

• About the Vaccine
  • Influenza Vaccine Composition & Major Differences
    Includes major differences between inactivated vaccine (TIV) and live attenuated influenza vaccine (LAIV).
  • Comparisons of LAIV and TIV Efficacy
• Vaccination Coverage Levels
• Options for Controlling Influenza
• Influenza Vaccine Supply Considerations
• Dosage, Administration, and Storage
• Indications and Contraindications
  • Persons for Whom Annual Vaccination is Recommended
  • Recommendations for Using TIV and LAIV During the 2007-08 Influenza Season
    Target groups for vaccination.
  • Vaccination of Specific Populations
    Children, persons aged 50-64 years, healthcare personnel, close contacts of immunocompromised persons, pregnant women, breastfeeding mothers, travelers, and the general population.
  • Persons Who Should Not Be Vaccinated
  • Timing of Vaccination
• Adverse Events
  • Adverse Events After Receipt of TIV
  • Adverse Events After Receipt of LAIV

• Content Source: Coordinating Center for Infectious Diseases (CCID)
• National Center for Immunization and Respiratory Diseases (NCIRD)

• Email page
• Print page
• Get Email Updates
• RSS

What You Should Know About …

Info for Health Professionals

• 2007-08 ACIP Recommendations
• Vaccination
• Antiviral Drugs
• Infection Control
• Clinical Description & Lab Diagnosis
• Free Flu Materials
• 2008 National Influenza Vaccination Week (NIVW)
• Flu Activity & Surveillance
• Training
• References & Resources

Info for Specific Groups

Other Flu Websites

• Avian Flu
• Pandemic Flu
• Swine Flu

Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A.
800–CDC–INFO (800-232-4636), 888–232–6348 (TTY), cdcinfo@cdc.gov